GlassScriptPhysician profile
Lisa M H Deppmeier
NPI 1871886697
$3,747.14
in general payments reported to CMS, 2019-2025
19 companies · $568 in 2025
The $568 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $739 · 2022: $654 · 2023: $626 · 2024: $1,160 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,353.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,040.39 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,032.02 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $577.62 | 2021-2025 | Dupixent |
| Genentech USA, INC. | $172.73 | 2021-2025 | Xolair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.86 | 2021-2023 | Jardiance |
| Lilly USA, LLC | $131.97 | 2021-2024 | Mounjaro, Zepbound |
| Amgen INC. | $129.81 | 2021-2025 | Otezla, Repatha, Prolia |
| Genzyme Corporation | $95.44 | 2024 | |
| Leo Pharma INC. | $72.81 | 2022-2025 | Adbry, Anzupgo |
| Novo Nordisk INC | $69.55 | 2021-2025 | Ozempic |
| Abbott Laboratories | $68.04 | 2022-2025 | Freestyle Libre 3 |
| Abbvie INC. | $57.83 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.77 | 2021 | |
| Merck Sharp & Dohme LLC | $29.68 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Oyster Point Pharma, INC. | $23.58 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.48 | 2025 | The Cologuard Plus Collection Kit |
| Esperion Therapeutics, INC. | $21.18 | 2025 | Nexletol |
| Insulet Corporation | $19.28 | 2024 | Omnipod |
| Arcutis Biotherapeutics, INC. | $17.10 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Deppmeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.